VILINBIO logo

Vilin BIO MED Limited

VILINBIO·NSE·
47.00 +0.05 (+0.11%)
Market Cap27.45 Cr
PE Ratio293.75
Volume12,000
Day High - Low48.50 - 46.00
52W High-Low54.40 - 18.95
DocStoX Score
5.1/10
Weak
Fair Value
Sign in to see
ROE
7.51%
Weak
P/E
293.75x
Expensive
Debt / Equity
0.11
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day46.00
48.50
52W18.95
54.40
DocStoX take

Supported by growth (10.0) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0 and quality at 2.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.1
/10
Weak
Quality
Weak
ROE 7.5%
Valuation
Expensive
P/E 200.0×
Growth
Strong
Revenue +29.6% 5Y CAGR
Risk
Moderate
D/E 0.11
Momentum
Strong
79% of 52-week range

At a glance

Market Cap
₹27 Cr
52W High / Low
₹54 / ₹19
Dividend Yield
0.00%
Promoter Holding
56.65%
EPS (TTM)
₹0.16
Book Value
₹18.60

Key highlights

  • Profit compounding 75% a year
  • Low leverage — D/E 0.11
  • Revenue compounding 30% a year
  • Valuation is weak (0.0/10)
  • Expensive at 200× earnings
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

VILIN BIO MED LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.